Latest News Archive

Please select Category, Year, and then Month to display items

Education dominates Qwaqwa Campus Teaching and Learning Awards

17 July 2020 | Story Thabo Kessah | Photo UFS photo archive

The Faculty of Education on the Qwaqwa Campus has recently dominated the Centre for Teaching and Learning’s (CTL) Excellence in Learning and Teaching Awards, as well as the Research Awards for 2019/2020. The faculty’s Drs Bunmi Omodan and Maria Tsakeni were placed first and second respectively in the category Research in Teaching and Learning. This was on top of the faculty’s accolade in the category Faculty/Department that is the most involved in Teaching and Learning events and practices on the Qwaqwa Campus.

“The faculty is indeed proud to be associated with these fine scholars and the excellence they represent,” said Faculty of Education Dean,Prof Loyiso Jita, in a congratulatory message to the faculty members.

“To the winners, please continue to live our emerging vision of ‘Representing and using our diversity, excellence in scholarship on research and teaching, and an ethic of care and service’ to produce teachers with balanced knowledge and skills and a consciousness to serve all of society in its diversity,” he added.

Winners from the faculty for the Research Awards were Dr Bekithemba Dube as the Most Prolific Researcher in the Faculty of Education and Dr Sekitla Makhasane in the category Best Emerging Researcher in the Faculty of Education.

It is the first time in years that all four faculties received Learning and Teaching Awards. Institutional awards are scheduled for September 2020.

The full list of winners is as follows:

Excellence in Learning and Teaching Awards:

Category: Research in Learning and Teaching:

Position 1: Dr Bunmi Omodan (Faculty of Education)

Position 2: Dr Maria Tsakeni (Faculty of Education)

Category: Innovation in Learning and Teaching:

Position 1: Dr Diana Breshears and Rentia Engelbrecht (The Humanities)

Position 2: Prof Aliza le Roux (Natural and Agricultural Sciences)

Position 3: Lebohang Masoabi (Economic and Management Sciences)

Position 4: Dr Maria Tsakeni (Faculty of Education)

Category: Faculty / Departmental Award

Faculty of Education (with special mention of Dr Cias Tsotetsi; Dr Maria Tsakeni; Thabiso Motsoeneng; and Dr Sekitla Makhasane).

Research Awards per faculty:

Education

Most Prolific Researcher: Dr Bekithemba Dube (School of Education Studies)

Best Emerging Researcher: Dr Sekitla Makhasane (School of Education Studies)

The Humanities

Most Prolific Researcher: Dr Oliver Nyambi (Department of English)

Best Emerging Researcher: Dr Tshepo Moloi (Department of History)

Natural and Agricultural Sciences

Most Prolific Researcher: Prof Francis Dejene (Department of Physics)

Best Emerging Researcher: Dr Lehlohonolo Koao (Department of Physics)

Economic and Management Sciences

Most Prolific Researcher: Dr Calvin Mudzingiri (Department of Economics and Finance)

Best Emerging Researcher: Dr Charity Gomo (Department of Economics and Finance)

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children

2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept